Technology News and Research

RSS

Study defines specific genetic mechanism that explains some of schizophrenia's heritability

The overall number and nature of mutations—rather than the presence of any single mutation—influences an individual's risk of developing schizophrenia, as well as its severity, according to a discovery by Columbia University Medical Center researchers published in the latest issue of Neuron.

29 May 2014

Monongalia General Hospital selects Agfa HealthCare’s DR Retrofit technology

Agfa HealthCare announced today that Monongalia General Hospital has selected the company's DX-D Retrofit with dual cesium wireless detectors to convert an existing analog X-ray room into a fully digital system.

28 May 2014

Ebola research: an interview with Professor Easton, University of Warwick

Ebola virus belongs to a group of viruses that have been known for some time. It was first isolated as a result of an infection in a primate, in a monkey colony, in monkeys that were being used for research in the Philippines.

28 May 2014

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

BioTime, Inc. today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications.

28 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

Scientists collect new data on how "tumor suppressor" gene works

Scientists armed with a supercomputer and a vast trove of newly collected data on the body's most potent "tumor suppressor" gene have created the best map yet of how the gene works, an accomplishment that could lead to new techniques for fighting cancers, which are adept at disabling the gene in order to thrive.

28 May 2014

Merck Serono launches web-based software system for MS patients receiving Rebif treatment

A new web and app-based software solution, launched in the UK today on World MS Day, will allow physicians and nurses to monitor treatment of patients taking MS disease-modifying treatment Rebif by collecting injection history through the new RebiSmart 2.0 electronic autoinjector.

28 May 2014

arGEN-X collaborates with Bayer Pharma for development of therapeutic antibodies

arGEN-X, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, announced today the initiation of a collaboration with Bayer Pharma AG (Bayer), leveraging arGEN-X's SIMPLE Antibody™ technology for the discovery and development of therapeutic antibodies.

28 May 2014

'Signglasses' system may help deaf literacy

Ordinarily, deaf students are left in the dark when they visit a planetarium. With the lights off, they can't see the ASL interpreter who narrates their tour of outer space. With the lights on, they can't see the constellations of stars projected overhead.

28 May 2014

Socioeconomic status appears to influence type of cancer a person may develop

A new analysis has found that certain cancers are more concentrated in areas with high poverty, while other cancers arise more often in wealthy regions. Also, areas with higher poverty had lower cancer incidence and higher mortality than areas with lower poverty.

28 May 2014

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Spokane Valley Cancer Center joined the Seattle Cancer Care Alliance (SCCA) Network to become its 12th Member in the Northwest this month. This relationship will expand access to cancer treatment options and help foster advances in cancer care in the greater Spokane community.

28 May 2014

New research program to understand and treat debilitating psychiatric disorders

Scientists and physicians at UC San Francisco (UCSF) are leading a $26 million, multi-institutional research program in which they will employ advanced technology to characterize human brain networks and better understand and treat a range of common, debilitating psychiatric disorders, focusing first on anxiety disorders and major depression.

28 May 2014

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

Developmental biologists at Tufts University, using a tadpole model, have shown that bioelectrical signals from distant cells control the incidence of tumors arising from cancer-causing genes and that this process is impacted by levels of a common fatty acid produced by bacteria found in the tadpole and also in humans.

28 May 2014

New analysis finds that certain cancers are more concentrated in areas with high poverty

28 May 2014

State regulators seek to impose controls on new painkiller

Several outlets look at prescription drug issues, including how to handle Zohydro -- a powerful painkiller approved by the FDA in March, and ethical questions raised by new "smart pills."

28 May 2014

Patents for new method to rid carpets and mattresses of harmful allergens that cause asthma

A team of researchers from the University of South Carolina received two patents for a new method to rid carpets, mattresses and other furniture of harmful allergens and pests that cause asthma.

28 May 2014

Researchers develop new technology that uses HIV virus as tool to fight against hereditary diseases

For the first time researchers have succeeded in altering HIV virus particles so that they can simultaneously, as it were, 'cut and paste' in our genome via biological processes. Developed at the Department of Biomedicine at Aarhus University, the technology makes it possible to repair genomes in a new way.

28 May 2014

Neural engineers to develop techniques for dynamic deep brain stimulation

Deep brain stimulators, devices that zap Parkinson's disease tremors by sending electrical current deep into nerve centers near the brain stem, may sound like they are cutting-edge, but Rice University's Caleb Kemere wants to give them a high-tech overhaul.

28 May 2014

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

A drug's half-life indicates how long a substance will remain active in the body. It is essentially the period of time that it takes for the concentration of the amount of the drug to be reduced by half, and therefore, determines how frequently a drug needs to be administered to maintain its therapeutic effect.

27 May 2014

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company's semiconductor-based synthetic gene manufacturing process.

27 May 2014

Technology News and Research

Study defines specific genetic mechanism that explains some of schizophrenia's heritability

Monongalia General Hospital selects Agfa HealthCare’s DR Retrofit technology

Ebola research: an interview with Professor Easton, University of Warwick

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Scientists collect new data on how "tumor suppressor" gene works

Merck Serono launches web-based software system for MS patients receiving Rebif treatment

arGEN-X collaborates with Bayer Pharma for development of therapeutic antibodies

'Signglasses' system may help deaf literacy

Socioeconomic status appears to influence type of cancer a person may develop

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

New research program to understand and treat debilitating psychiatric disorders

Biologists show bioelectrical signals control tumors arising from cancer-causing genes, fatty acid

New analysis finds that certain cancers are more concentrated in areas with high poverty

State regulators seek to impose controls on new painkiller

Patents for new method to rid carpets and mattresses of harmful allergens that cause asthma

Researchers develop new technology that uses HIV virus as tool to fight against hereditary diseases

Neural engineers to develop techniques for dynamic deep brain stimulation

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News